Tuesday 01st of May 2018
Organized by the BioScope group |
 |
In collaboration with the |
 |
| Scientific Program |
|
Contact email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it , This e-mail address is being protected from spambots. You need JavaScript enabled to view it Posters and extended abstracts will be published at no cost in the open Journal JIOMICS (www.jiomics.com). DOI number will be assigned for each one. In addition the best posters and extended abstract will be awarded. Method of election: by voting of the conference participants. Conference Timetable (coming soon)
Schedule:
Monday and Wednesday: 8:30-9 poster session. 9-12 and 14-17 plenary conferences and talks
Tuesday: 8:30-9 poster session. 9-12 plenary conference and talks.
Conference Subjects
Harald Mischak, PhD
Mellendorfer Diagnostics, Germany and University of Glasgow, United Kingdom.
Subject: Urinary proteomics: from discovery to routine clinical application.
J. L. Capelo, PhD
REQUIMTE, Chemistry Department, Faculty of Sciences and Technology, UNL, Caparica, Portugal.
Subject: Nanoparticles as a tool in profiling Urine
Hugo Baptista Carreira dos Santos, PhD
REQUIMTE, Chemistry Department, Faculty of Sciences and Technology, UNL, Caparica, Portugal.
Subject: Arthritis: what urine can tell us?
Evelyne Meyer, PhD
Department of pharmacology and Biochemistry, Kent University, Belgium.
Subject: Urinary-proteomics identified novel biomarker for acute kidney injury.
Clizia Chinello, PhD
Depart. of Health Sciences, University of Milano-Bicocca, Italy.
Subject: Comparison of Label-free nLC MS/MS and MALDI-TOF approaches to evaluate alterations in urinary peptidome of RCC patients.
Fulvio Magni, PhD
Depart. of Health Sciences, University of Milano-Bicocca, Italy.
Subject: Alterations of urinary peptidome in kidney tumors.
Francisco J. Lopez-Hernandez, PhD
Researcher, IBSAL-IECSCYL & Associate Professor, Universidad de Salamanca, Salamanca, Spain.
Subject: New urinary biomarkers (by proteomics) for new concepts and strategies aimed at the preventive diagnosis of acute kidney injury
United Kingdom.
Subject: Data mining to discovery dietary exposure biomarkers.
John Draper, PhD
United Kingdom.
Subject: Sampling methods to deal with the dynamic and non-homeostatic nature of urine composition.
Gert Mayer, PhD
Director, Department of Internal Medicine IV (Nephrology and Hypertension), Medical University of Innsbruck. Austria.
Subject: Building a useful model from multiple markers and profiles.
Liang Li, PhD
Professor of Chemistry, Adjunct Professor of Biochemistry & Canada Research Chair in Analytical Chemistry
Subject: Comprehensive and quantitative urine meabolome profiling by isotope labeling LC-MS.
Xiaoyan Fu, PhD
Department of Anatomy and Neurobiology. School of Medicine. Washintong University in St. Louis. USA.
Subject: The metabolomics of mouse.
Bogdan A . Czerniak, PhD
Department of Pathology. UT MD Anderson Cancer Center. Houston, United States.
Subject: Detection of bladder cancer using voided urine based tests.
Annalisa Castagna, PhD
University of Verona. Department of Medicini. Unit of Internal Medicine. Verona. Italy.
Subject: Urinary Proteomcis Anlaysis from Urinary exosomes.
Je Kyung Seong, PhD
Laboratory of Developmental Biology and Genomics, Seoul National University, Seoul, S. Korea.
Subject: Pending of Confirmation.
Tony Parker, PhD
Tissue Repair and Regeneration Program & Workforce Health Innovation Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia
Subject: Urinary biomarkers of musculoskeletal injury and physical activity
Huan-Tsung Chang, PhD
Department of Chemistry, National Taiwan University, Taipei, Taiwan.
Subject: Pending Confirmation.
Gene Wijffels, PhD
Research Program Leader - Integrated Mammalian Biology CSIRO Animal, Food and Health Sciences. Australia.
Subject: Pending Confirmation.
Dimitrios Kirmizis, PhD
Department of Nephrology. Hippokration General HospitalAristotle University. Thessaloniki.
Subject: The need for novel urinary biomarkers: from bedside to the bench
Peter Karlheinz, PhD
National Health and Medical Research Council. Australian Vascular Biology Society. Melbourne, Australia.
Subject: Pending Confirmation.
Hitoshi Osaka, PhD
Dept. of Neurology. Kanawaga Children´s Medical Center. Clinical Biochemisctry. Clinical research Institution. Mutsukawa. Minami-Ku. Yokohama. Japan.
Subject: A simple screening method using ion chromatography for the diagnosis of cerebral creatine deficiency syndromes.
Michael Rychlik, PhD
Chair of Analytical Food Chemistry. Technical University of Munich. Germany.
Subject: Suitable urinary biomarkers for assessing exposure to mycotoxins.
Susan Sumner, PhD
Subject: Pending of Confirmation.
Blanka Stiburkova, PhD
Charles University in Prague, First Faculty of Medicine, Institute of Inherited Metabolic Disorders, Prague, Czech Republic.
Subject: The role of urate transporters in diseases linked to renal hypouricemia.
Simone Köning, PhD
Integrated Functional Genomics, Interdisciplinary Center for Clinical Research, University of Münster, Germany.
Subject: pending of confirmation.
Michael Goligorsky, PhD
Professor of Medicine, Pharmacology and Physiology, Academic Chief. Division of Nephrology, Director. Renal Research Institute, New York Medical College, New York, USA.
Subject: urine proteome of transplant rejection and chronic allograft nephropathy
Tzu-Ling Tseng, PhD
Senior Director, Biomedical Technology & Device Research Laboratories (BDL), Industrial Technology Research Institute (ITRI), Taipei, Taiwan.
Subject: Develop Urinary Biomarkers for Managing Chronic Kidney Disease
Evgeny Nikolaev, PhD
Head of Laboratory of Mass Spectrometry of Biomacromolecules, Institute for Biochemical Physics Russian Academy of Sciences, Moscow, Russia.
Subject: pending of Confirmation.
Sylwia Magiera, PhD
Department of Analytical Chemistry. Silesian University of Technology
Subject: Separation and spectral techniques in the analysis of drugs and metabolites in human urine for clinical application.
Vladisav Stefanovic, PhD
University School of Medicine Nis, Serbia, Serbian Academy of Sciences and Arts.
Subject: Urine proteomics validated by tissue proteomics in balkan nephropathy, i.e. aristolochic acid nephropathy.
Irene Nunes, PhD
Merck & Co Rahway, New Jersey, USA.
Subject: NIH’s Clinical Qualification of Urine Acute Kidney Injury Biomarkers.
E. C. Zwarthoff, PhD
Department of Pathology, Josephine Nefkens Institute, Rotterdam, The Netherlands.
Subject: Diagnosis of Primary and Recurrent Bladder Cancer in Urine.
Michal Markuszewski, PhD
Poland.
Subject: Analysis of metabolic profiles as a biomarkers in urinary bladder cancer patients.
Yongyu Zhang, PhD
Center for Traditional Chinese Medicine and Systems Biology, Shanghai University of Traditional Chinese Medicine, Shangai, China.
Subject: Study on traditional chinese medicine syndrome (ZHENG) based on metabonomics.
Johan Ärnlöv, PhD
Associate Professor of Cardiovascular Epidemiology. Department of Public Health and Caring Sciences Uppsala University.
Subject: Urinary biomarkers and the risk of cardiovascular disease
Ying-Hsiu Su, PhD
Associate Professor. Department of Microbiology and Immunology, Drexel University College of Medicine. Philadelphia, PA, USA.
Subject: Application of circulation derived DNA in urine for cancer screening.
Manuel Valiente Malmagro, PhD
Autonoma University of Barcelona, Spain.
Subject: Pending Confirmation.
Jerry Morrissey, PhD
Department Anesthesiology. Division of Clinical and Translational Research. Washington University in St. Louis. USA.
Subject: Urine proteome of the acute kidney injury due to acute myocardial infarction.
Bárbara Gionco, MsD
Universidade Estadual de Londrina. Londrina. Brazil.
Subject: Diversity of Carbapenemases in clinical relevant non-fermenting gram-negative bacilli isolated from Urine
Alexander Hüttenhofer, PhD
Director, Division of Genomics & RNomics. Head, Core Facility Deep-Sequencing. Innsbruck Medical University-Biocenter, Austria.
Subject: URNomics: ncRNAs as diagnostic markers in diagnosis of chronic kidney.
Anna Lokshin, PhD
USA.
Subject: Protein and nucleus acid urine biomarkers.
Christiane Auray-Blais, PhD
Director. Provincial Mass Urine Screening Program. Scientific Director. Waters-CHUS Expertise Centre in Clinical Mass Spectrometry. Hospital Fleurimont, Quebec, Canada.
Subject: Urinary Biomarker Analysis: From Thin Layer Chromatography to Mass Spectrometry Applications.
Vincenzo Serretta, PhD
Associate Professor of Urology, Institute of Urology, Maternal-Infant Andrology and Urology Department, University of Palermo, Italy Subject: Pending Confirmation Rosemary Wangensteen, PhD Assistant Professor, Faculty of Health Sciences, University of Jaen, Spain. Subject: Urinary excretion of glutamyl aminopeptidase as a marker of renal damage. Kate E. Williamson, PhD Principal Investigator, Centre for Cancer Reserach and Cell Biology, Queen's University, Belfast, UK. Subject: Collectives of protein biomarkers as risk stratifiers and diagnostic classifiers in haematuria patients. Roby Bhattacharyya, PhD Broad Institute of MIT and Harvard; Massachusetts General Hospital, Division of Infectious Disease; Brigham and Women's Hospital, Division of Infectious Disease Subject: Transcriptional signatures in infectious disease diagnostics Giovanni Candiano, PhD Nephrology, Dialysis, Transplantation Unit and Laboratory on Pathophysiology of Uremia, Istituto Giannina Gaslini, Genova, Italy. Laura Santucci, PhD Nephrology, Dialysis, Transplantation Unit and Laboratory on Pathophysiology of Uremia, Istituto Giannina Gaslini, Genova, Italy. Subject: Pending of Confirmation. Alex Vorsters, PhD Centre for the evalluation of vaccination. Faculty of Medicine and Health Sciences. University of Antwerp. Belgium. Division of Applied medicine. School of Medicine. University of Aberdeen. UK.
Subject: Proteomic analysis of E. Coli isolates from urinary tract infections.
Hanno Steen, PhD
Boston Children's Hospital. Harvard Medical School. Boston. USA.
Subject: Urine proteomics reveals diagnostic biomarkers for pediatric acute inflammatory diseases.
Ching-Wan Lam, MBChB PhD
Department of Pathology, The University of Hong Kong, Hong Kong, China.
Subject: Quantitative high resolution 1H NMR urinalysis for algorithmic diagnosis of urinary tract infection using an automatic analyzer.
Timothy Bowen, PhD
Senior Lecturer in Matrix and Molecular Biology, Section of Nephrology, Institute of Molecular and Experimental Medicine, Cardiff University School of Medicine, Cardiff, UK.
Subject: Urinary microRNAs as biomarkers for chronic kidney disease.
Tatjana Crnogorac-Jurcevic, PhD
Centre for Molecular Oncology. Barts Cancer Institute. Queen Mary Hospital, University of London, London, UK.
Subject: Can urine be used to diagnose pancreatic Cancer?
Yuegang Zuo, PhD
Professor. Director of Graduate Programs, Department of Chemistry and Biochemistry. University of Massachusetts Dartmouth, North Dartmouth, USA.
Subject: Study of phenolic antioxidants in human plasma and urine after cranberry consumption.
Department of Urology. University Hospital Basel. University of Basel. Switzerland.
Subject: The heat is on - Rapid detection of urinary tract pathogens using isothermal microcalorimetry.
Giovanni Candianno, PhD
Nephrology, Dialysis, Transplantation Unit and Laboratory on Pathophysiology of Uremia.
Subject: Extensive discovery in human urinary proteome.
Y. S. Fung, PhD
Department of Chemistry, Hong Kong University, Hong Kong, China.
Subject: Microchip-capillary devices for metabolomics application
Antonia Vlahou, PhD
Biomedical Research Foundation Academy of Athens. Greece.
Subject: Fractionation Strategies for urine proteomics
Francesco broté, PhD
Laboratotio Antidoping, FMSI. Rome. Italy.
Subejct: Pending Confirmation.
Glen Ulett, PhD
Griffith University. Gold Coast QLD, Australia.
Subject: Metabolomics and Genomics of Human Urine Utilisation by Asymptomatic Bacteriuria Streptococcus agalactiae.
Vineta Vuksanovic
Subject: Pending Confirmation
Parmjeet Randhawa, PhD
Department of Pathology, Division of Transplantation Pathology, UPMC-Montefiore Hospital, Pittsburgh, PA, USA.
Subject: Genomic Analysis of Polyomavirus BK in urine of Kidney Transplant Patients.
Kamel S. Kamel, PhD
Professor of medicine. Head. Division of nefrology. St. Michael´s Hospital. University of Toronto. Canada.
Subject: Regulation of Urine pH and Pathophysiology of kidney stones"
David E. Nelson, PhD
Associate Professor of Medicine. Medical School Campus. Indiana. United States.
Subject: Does the male urogenital microbiome play roles in STI and idiopathic urethritis?
Carlo Donadio, PhD
Associate Professor of Nefrology. Dept. of Clinical and Experimental Medicine, University of Pisa, Italy.
Subject: Biochemical Analysis of urine of CKD Patients.
V. S. Chauhan, PhD
Director. International Centre for Geentic aEngeneering & Biotechnology. Aruna Asaf Ali Marg, New Delhi, India.
Subject: Pending Confirmation.
Lourdes Mengual Brichs, PhD
Hospital Clinic. Barcelona. Spain.
Subject: Development of a non-invasive diagnosis urine test for bladder cancer.
Vineta Vuksanovich, PhD
Cyprus.
Subject: Threatening gram-negative bacteria
Joost P. Schanstra, PhD
Institute of Metabolic and Cardiovascular Diseases. Toulouse, France.
Subject: Peptidomics in fetal and prenatal medicine.
Teresa Sousa, PhD
Department of Pharmacology ant Therapeutics, Centre for Medical Investigation, Faculty of Medicine. University of Oporto, Oporto, Portugal..
Subject: Urinary biomarkers in arterial hypertension and heart failure.
Carlos Donadio, PhD
Dto. Clinical and Experimental medicine. Division of Nephrology. University of Pisa. Italy.
Subject: From plasma to urne proteomics, passing through the nefron
Roumiana Tsenkova, PhD
Biomeasurement Technology Laboratory. Kobe University. Faculty of Agriculture. Japan.
Subject: Urine and Aquaphotomics for diagnosis.
Mario Calderesi, PhD
Kode (kode-solutions.net) & The University of Siena, NMR Centre.
Subject: The use of Metabolomics as an interpreting tool to understand kidney graft recipients recovery.
Doble Mukesh, PhD
Professor and Head. Department of Biotechnology. Bhupat & Jyoti Mehta School of BioSciences. Madras, India.
Subject: Diagnostic Significance of Urine Composition in Patients with Clinical Disorders
Pawel Jaruga, PhD
Biomolecular Measurement Division. Bldg. 227. NIST. Gaithersburg. United States.
Subject: DNA damage products R- and S- diastereomers of 8,5’-cyclo-2’-deoxyadenosine in human urine as potential biomarkers for aterosclerosis
Thomas Kislinger, PhD
Associate Professor. Department of Medical Biophysics. University of Toronto. Canada.
Subject: pending of confirmation
Anna Wasilewska, PhD
Professor. Department of Pediatrics and Nephrology. Białystok. Poland.
Subject: The role of urnie biomarkers in diagosis of congenital hydronephrosis?
Mark Schembri, PhD
Australian Infectious Disease Research Centre. School of Chemistry and Molecular Biosciences. University of Queensland. Australia.
Subject: Global analysis of genes important for growth of Uropathogenic E. coli in human urine
Miral Dizdaroglu, PhD
NIST Fellow. Biomolecular Measurement Division. National Institute of Standards and Technology. Gaithersburg. USA.
Subject: Identification and quantification of 8,5’-cyclo-2’-deoxyadenosines as disease biomarkers in human urine by liquid chromatography-tandem mass spectrometry.
Hung-Yin Lin, PhD
Department of Chemical and Materials. Engineering at National University of Kaohsiung (NUK). Taiwan.
Subject: Optical Sensing of Urinary Melatonin with Molecularly Imprinted Poly(ethylene-co-vinyl alcohol) Coated Zinc Oxide Nanorod Arrays
Xiaoyan Fu, PhD
Department of anatomy and neurobiology school of medicine. Washington University in St. Louis.
Subject: A molecular foundation for identity in mouse vomeronasal olfaction
José Antonio Tesser Poloni, PhD
Irmandade da santa casa de Misericórdia de Porto Alegre and Universidade Federal de Ciências da Saude de Porto Alegre.
Subject: Urinalysis as a diagnostic tool to detect infectious diseases on patients under immunosuppression: new perspectives to an old method.
Laddawan Potprommanee, MsD
Institute of Biological Chemistry, Academia Sinica, Taipei. Taiwan.
Subject: GM2-activator protein: A potentital biomarker for lung cancer identified by urine proteome analysis.
Paitoon Aobchei, PhD
Science and Technology Research Institute. Chiang Mai University. Chiang Mai. Thailand.
Subject: Proteomic strategies for biomarker identiifcation in cervical cancer urine.
Kannan Valdyanathan, PhD
Professor & Head, Department of Biochemistry, Pushpagiri Institute of Medical Science & Research Center, Thiruvalla, Kerala, India
Subject: Urinalysis for the diagnosis of inborn errors of metabolism
Hy Lan, PhD
Professor of Biomedical Sciences. Director, Inflammatory Disease Research. Department of Medicine &Therapeutics and Li Ka Shing Institute of Health Sciences. The Chinese University of Hong Kong. Shatin. NT. Hong Kong.
Subject: Urinary TGF-beta as a biomarker for chronic kidney disease
Katsumi Shibata, PhD
Department of Food Science and Nutrition. School of Human Cultures. The University of Shiga Prefecture. Hassakacho. Hikone. Shiga. Japan
Subject: Fate of dietary tryptophan in young japanese women Milan N. Stojanovic, PhD
Deparments of Medicine and Biomedical Engineering, Columbia University, USA
Subject: Aptameric sensors for quantitation of amino acids and sugars Ian A. Brewis, PhD
Central Biotechnology Services, Institute of Translation, Innovation, Methodology and Engagement (TIME), School of Medicine, College of Biomedical and Life Sciences, Cardiff University. Cardiff, UK
Subject: Exosome proteomics to better understand bladder cancer Jentaie Shiea, PhD
Department of Chemistry, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Subject: Characterizing polar metabolites in urine using Gas Chromatography/Electrospray Ionization/Mass Spectrometry Bakaj Aurora, PhD
Departamenti i Biologjisë, Universiteti i Tiranës, Fakulteti i Shkencave Natyrore, Bulevardi Zogu I. Tiranë, Albania.
Subject: The comparison of urinalysis parameters in pregnant and nonpregnant women in Berat. Shoji Kagami, PhD
Department of Pediatrics, The Institute of Health Bioscience, The University of Tokushima Graduate School, Tokushima, Kuramoto-cho-3-18-15, Tokushima 770-8503, Japan.
Subject: Urinary angiotensinogen as a biomarker of chronic glomerulonephritis in childhood. Carlo Donadio, PhD
Dipartimento di Medicina Clinica e Sperimentale, Divisione di Nefrologia, Università di Pisa, Italy.
Subject: Urinary low-molecular weight proteins for detecting early impairments in glomerular filtration rate.Sara Bravaccini, PhD
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) S.r.l., Italy.
Subject: Usefulness of biomarkers in the detections of bladder cancer in the clinical practic.Shot Gun Presentations
Sarath Kiran Channavajjhala, MsD
University of Verona. Department of Medicini. Unit of Internal Medicine. Verona. Italy.
Subject: Urinary Proteomcis Anlaysis from Urinary exosomes. Kristina Daniunaite Subject: Frequent DNA methylation of tumour suppressor genes in urine sediments from patients with early-stage prostate cancer. Poster Presentations Prof. Irena Staneczko-Baranowska, PhD Department of Analytical Chemistry. Silesian University of Technology. Poland. Subject: Methodology for a rapid and simultaneous determination of selected drugs and their metabolites in Human urine by UHPLC-MS/MS. Arkady Braun and Igor Rodin Subject: Determination of nerve agents metabolites in human urine by liquid chromatography-tandem mass spectrometry. Subject: Rapid method for the detection of lewisite metabolite - 2-chlorovinylarsonous acid in urine by liquid chromatography electrospray-tandem mass spectrometry. Kristina Stuopelyte Subject: miRNA expression analysis un urine sediments of prostate cancer patients. Elena Ukolova Subject: Systematic toxicological screening of biolomedical samples by gc-ms and lc-ms/ms. an lc-ms/ms identification of neostigmine and its metabolites. Tatiana Morozova Subject: Experience in the participation of the research institute of hygiene, occupational pathology and human ecology in biomedical confidence building exercises. Zahra Sedaghat Subject: Remote per-conditioning a new strategy to protect the kidney from ischemia/reperfusion injury evidenced by reduced urinary protein and creatinine. |
© 2012 Bioscope Research Group